Product Code: ANV1012
Reprt Highlight:
Restriction Endonucleases Market size was valued at USD 360.8 Million in 2021, expanding at a CAGR of 7.7% from 2022 to 2028.
In order to produce distinct DNA fragments that can be distinguished by gel electrophoresis, restriction endonuclease, an enzyme, cuts the DNA molecule at or close to a certain nucleotide sequence.
Market Dynamics
The increased use of restriction endonuclease enzymes in a variety of applications, including cloning, sequencing, and restriction digestion, is the main driver contributing to the market's growth. Moreover, the financial support and investment made by pharmaceutical and biotechnology firms. The key growth drivers for this market include rising funding for genetics and life science, an aging population, and the rising prevalence of chronic diseases like diabetes, cardiovascular disease, and cancer. The manufacture of restriction endonucleases is expensive, which limits market expansion.
The market for restriction endonucleases is anticipated to expand throughout the course of the forecast period as a result of rising biotechnology and pharmaceutical industry spending on research and development. Additionally, recently developed technologies like DNA sequencing and gene expression are anticipated to drive market expansion. Nucleotides are retrieved from DNA in a certain order through a process called sequencing. This method contributes to the market expansion for molecular biology enzymes, kits, and reagents. The demand for clinical information systems is rising as a result of the growing need for healthcare facilities in both developed and emerging nations. Furthermore, this rise in R&D effort is being supported by increased investment and the support of funding by the government is also fueling the market growth. The existence of prominent players, significant investments, expanding biotechnology research & development programs the presence of pharmaceuticals in the area, and well-established healthcare infrastructure are all contributing factors to the market growth.
Segmentation Analysis:
The Global Restriction Endonucleases Market is segmented on the basis of Type, Application, End User, and Region.
The market is split into four categories based on Type: Type I, Type II, Type III, and Type IV. The Type II segment dominates the market. Growing demand for biological applications such as DNA analysis is mainly contributing to segment growth.
The market is segmented into four categories based on application: genetic engineering, DNA mapping, gene sequencing, and others. The DNA mapping segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the demand for DNA fragmentation needs.
The market is segmented into four categories based on end-users: Academic research, pharma-biotech, and others. The pharma-biotech segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the need for restriction endonucleases in pharma operations.
Competitive Landscape:
The worldwide market for restriction endonucleases is highly fragmented and comprised of large and small-sized market players with a few large ones dominating the global market share. Key players are emphasizing adopting aggressive strategies to capture significant revenue share. For instance, in October 2022, Pfizer completed the acquisition of Biohaven Pharmaceuticals to expand its gene-related product portfolio.
Key features of the study:
- This proposed research study on Restriction Endonucleases market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Restriction Endonucleases market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Restriction Endonucleases market
- Impact of COVID-19 on Restriction Endonucleases market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Restriction Endonucleases market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Restriction Endonucleases market, we have also included competitive landscape and key innovator analysis for the Restriction Endonucleases market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Restriction Endonucleases market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Restriction Endonucleases market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RESTRICTION ENDONUCLEASES MARKET KEY PLAYERS
- Thermo Fisher Scientific, Inc.
- Vertex Pharmaceuticals Inc.
- Takara Bio, Inc.
- Illumina, Inc.
- Promega Corp.
- Genetix Biotech Asia Pvt. Ltd.
- Merck & Co., Inc.
- Pfizer, Inc.
- PerkinElmer
- Abbexa
- Nippon Gene Co., Ltd.
- New England Biolabs Ltd.
- Agilent Technologies, Inc.
- F. Hoffmann La Roche Ltd.
- Amgen, Inc.
- Abcam PLC
- Sisco Research Laboratories Pvt. Ltd
GLOBAL RESTRICTION ENDONUCLEASES MARKET, BY TYPE
- Type I
- Type II
- Type III
- Type IV
GLOBAL RESTRICTION ENDONUCLEASES MARKET, BY APPLICATION
- Genetic engineering
- DNA mapping
- Gene sequencing
- Others
GLOBAL RESTRICTION ENDONUCLEASES MARKET, BY END USER
- Academic Research
- Pharma-biotech
- Others
GLOBAL RESTRICTION ENDONUCLEASES MARKET, BY REGION
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Restriction Endonucleases Market Overview
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Market Snippet by Type
- 2.1.2. Market Snippet by Application
- 2.1.3. Market Snippet by End User
- 2.1.4. Market Snippet by Country
- 2.1.5. Market Snippet by Region
- 2.2. Competitive Insights
3. Restriction Endonucleases Key Market Trends
- 3.1. Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Future Trends
4. Restriction Endonucleases Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Restriction Endonucleases Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Restriction Endonucleases Market Landscape
- 6.1. Market Share Analysis, 2021
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Restriction Endonucleases Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2021 & 2028 (%)
- 7.1.2. Type I
- 7.1.3. Type II
- 7.1.4. Type III
- 7.1.5. Type IV
8. Restriction Endonucleases Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2021 & 2028 (%)
- 8.1.2. Genetic engineering
- 8.1.3. DNA mapping
- 8.1.4. Gene sequencing
- 8.1.5. Others
9. Restriction Endonucleases Market - By End User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2021 & 2028 (%)
- 9.1.2. Academic Research
- 9.1.3. Pharma-biotech
- 9.1.4. Others
10. Restriction Endonucleases Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11. Key Vendor Analysis
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Thermo Fisher Scientific, Inc.
- 11.2.2. Vertex Pharmaceuticals Inc.
- 11.2.3. Takara Bio, Inc.
- 11.2.4. Illumina, Inc.
- 11.2.5. Promega Corp.
- 11.2.6. Genetix Biotech Asia Pvt. Ltd.
- 11.2.7. Merck & Co., Inc.
- 11.2.8. Pfizer, Inc.
- 11.2.9. PerkinElmer
- 11.2.10. Abbexa
- 11.2.11. Nippon Gene Co., Ltd.
- 11.2.12. New England Biolabs Ltd.
- 11.2.13. Agilent Technologies, Inc.
- 11.2.14. F. Hoffmann La Roche Ltd.
- 11.2.15. Amgen, Inc.
- 11.2.16. Abcam PLC
- 11.2.17. Sisco Research Laboratories Pvt. Ltd
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us